Migraine prevention with Petasites
Diener, H.C.
Medizinische Monatsschrift für Pharmazeuten 29(1): 40
2006
ISSN/ISBN: 0342-9601 PMID: 16463557 Document Number: 599994
Document emailed within 1 workday
Related Documents
Schuck, P.; Böhmer, K.; Resch, K.L. 1999: Migraine and prevention of migraine: the value of magnesium Schweizerische Medizinische Wochenschrift 129(3): 63-70Xie, Y.-y.; Li, Y.-x.; Sun, Y.-m.; Wang, Y.; Guo, M.-l. 2016: A new anti-hypoxia sesquiterpene from the rhizome of Petasites japonicas Yao Xue Xue Bao 51(8): 1285-1289
Ledić, P.; Antoncić, N.; Sepcić, J. 1973: BC-105 in the prevention of migraine Neuropsihijatrija 21(3-4): 291-296
Heuser, B.; Middendorf, E. 1985: Migraine prevention with dihydroergotamine Fortschritte der Medizin 103(41): 966-970
Bermejo Velasco, P.Emilio.; Velasco Calvo, Río. 2007: New antiepileptic drugs in migraine prevention Medicina Clinica 128(10): 379-382
Montastruc, J.L.; Senard, J.M. 1992: Calcium channel blockers and prevention of migraine Pathologie-Biologie 40(4): 381-388
Kollin, E. 1971: Experience with a new serotonin antagonist in the prevention of migraine Orvosi Hetilap 112(35): 2090 Passim
Carasso, R.L.; Yehuda, S. 1984: The prevention and treatment of migraine with an analgesic combination British Journal of Clinical Practice 38(1): 25-27
Schoonman, G.G.; Wiendels, N.J.; Ferrari, M.D. 2004: Still no proof of the efficacy of acupuncture in the prevention of migraine Nederlands Tijdschrift Voor Geneeskunde 148(44): 2165-2166
Einecke, D. 2001: Therapy and prevention of migraine. New recommendations and their practical application MMW Fortschritte der Medizin 143(8): 4-7
Israil, A.; Ahmed, S.; Rahman, K.M.; Uddin, M.J.; Dey, S.K.; Battacharjee, M.; Mondal, G.; Ali, M.A.; Alam, M.N.; Miah, A.H.; Uddin, M.S. 2013: Efficacy of amitriptyline, pizotifen and propranolol in the prevention of migraine Mymensingh Medical Journal: Mmj 22(1): 93-100
Grotemeyer, K.H.; Schlake, H.P.; Husstedt, I.W. 1988: Prevention of migraine with metoprolol and flunarizine. A double-blind crossover study Der Nervenarzt 59(9): 549-552
Langohr, H.D.; Reinecke, M.; Gerber, W.D.; Mangold, R. 1988: Dihydroergotamine and flunarizine in the prevention of migraine. A comparative double-blind study Fortschritte der Medizin 106(2): 65
Pothmann, R. 1987: Prevention of migraine with flunarizine and acetylsalicylic acid. A double-blind study Monatsschrift Kinderheilkunde: Organ der Deutschen Gesellschaft für Kinderheilkunde 135(9): 646-649
Frenken, C.W.; Nuijten, S.T. 1984: Flunarizine--a new agent for migraine prevention. Results of a double-blind comparison with placebo Fortschritte der Medizin 102(12): 349-351
Vo, A.H.; Satori, R.; Jabbari, B.; Green, J.; Killgore, W.D.S.; Labutta, R.; Campbell, W.W. 2007: Botulinum toxin type-a in the prevention of migraine: a double-blind controlled trial Aviation Space and Environmental Medicine 78(5 Suppl): B113-B118
Wörz, R.; Reinhardt-Benmalek, B.; Föh, M.; Grotemeyer, K.H.; Scharafinski, H.W. 1992: Prevention of migraine using bisoprolol. Results of a double-blind study versus metoprolol Fortschritte der Medizin 110(14): 268-272
Rompel, H.; Bauermeister, P.W. 1970: Aetiology of migraine and prevention with carbamazepine (Tegretol): results of a double-blind, cross-over study South African Medical Journal 44(4): 75-80
Castillo, J.; Martínez, F.; Corredera, E.; Lema, M.; Noya, M. 1995: Migraine and histamine: determining histidine in plasma and cerebrospinal fluid during migraine attacks Revista de Neurologia 23(122): 749-751
Sjaastad, O.; Bovim, G.; Stovner, L.J. 1992: Laterality of pain and other migraine criteria in common migraine. a comparison with cervicogenic headache Functional Neurology 7(4): 289-294